Cargando…

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data

BACKGROUND: The tendency of amyloid-β to form oligomers in the blood as measured with Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) is a valuable biomarker for Alzheimer’s disease and has been verified with heparin-based plasma. The objective of this study was to evaluate the performance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youn, Young Chul, Kim, Hye Ryoun, Shin, Hae-Won, Jeong, Hae-Bong, Han, Sang-Won, Pyun, Jung-Min, Ryoo, Nayoung, Park, Young Ho, Kim, SangYun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641916/ https://www.ncbi.nlm.nih.gov/pubmed/36344984 http://dx.doi.org/10.1186/s12911-022-02024-z

Ejemplares similares

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
por: Babapour Mofrad, Rosha, et al.
Publicado: (2021)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

(11)C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn, Young Chul, et al.
Publicado: (2017)

Oligomerization by co-assembly of β-amyloid and α-synuclein
por: Kim, Jin Ryoun
Publicado: (2023)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer’s disease
por: Kim, Nam Heon, et al.
Publicado: (2023)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017)

Detection of cognitive impairment using a machine-learning algorithm
por: Youn, Young Chul, et al.
Publicado: (2018)

Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers
por: Jung, Young Hee, et al.
Publicado: (2020)

Novel PSEN1 G209A mutation in early-onset Alzheimer dementia supported by structural prediction
por: An, Seong Soo A., et al.
Publicado: (2016)

Classification of Aβ State From Brain Amyloid PET Images Using Machine Learning Algorithm
por: Simfukwe, Chanda, et al.
Publicado: (2023)

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-β and Reverses Cognitive Deficits in Alzheimer Transgenic Mice
por: Lee, Sang-Hyun, et al.
Publicado: (2014)

P300 latency changes in patients with mild cognitive impairment after taking choline alphoscerate; A preliminary study
por: Han, Su-Hyun, et al.
Publicado: (2018)

Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease
por: Park, Young Ho, et al.
Publicado: (2021)

Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
por: Lee, Dongtak, et al.
Publicado: (2021)

Coping with Dementia in the Middle of the COVID-19 Pandemic
por: Ryoo, Nayoung, et al.
Publicado: (2020)

Predicting progression to dementia with “comprehensive visual rating scale” and machine learning algorithms
por: Park, Chaeyoon, et al.
Publicado: (2022)

Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2020)

Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET
por: Oh, Se Jong, et al.
Publicado: (2018)

Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation
por: Wolff, Martin, et al.
Publicado: (2015)

Association between Cerebral Amyloid Deposition and Clinical Factors Including Cognitive Function in Geriatric Depression: Pilot Study Using Amyloid Positron Emission Tomography
por: Kim, Hye-Geum, et al.
Publicado: (2016)

Probable novel PSEN2 Val214Leu mutation in Alzheimer’s disease supported by structural prediction
por: Youn, Young Chul, et al.
Publicado: (2014)

[(18)F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings
por: Oh, Minyoung, et al.
Publicado: (2022)

Author Correction: Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2021)

Use of the Clock Drawing Test and the Rey–Osterrieth Complex Figure Test-copy with convolutional neural networks to predict cognitive impairment
por: Youn, Young Chul, et al.
Publicado: (2021)

Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET
por: Kim, Soo-Jong, et al.
Publicado: (2022)

Centiloid method evaluation for amyloid PET of subcortical vascular dementia
por: Yun, Hyuk Jin, et al.
Publicado: (2017)

Extracellular vesicles: where the amyloid precursor protein carboxyl‐terminal fragments accumulate and amyloid‐β oligomerizes
por: Pérez‐González, Rocío, et al.
Publicado: (2020)

Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment
por: Jang, Hyemin, et al.
Publicado: (2018)

Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals
por: Jeong, Young Jin, et al.
Publicado: (2023)

Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis
por: Kim, Seok Jin, et al.
Publicado: (2016)

Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET
por: Kim, Si Eun, et al.
Publicado: (2020)

Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow
por: Choi, Yoon Jung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mo21qsfnaa13tek63dte15akfj